Form 4: Saba Capital Management Reduces Stake in BlackRock Capital Allocation Term Trust

Saba Capital Management, a 10% owner and director, has decreased its holdings in BlackRock Capital Allocation Term Trust (BCAT) through recent sales.

Summary

• Saba Capital Management, L.P., along with director Boaz Weinstein, reported changes in their beneficial ownership of BlackRock Capital Allocation Term Trust (BCAT) common stock.
• On February 20, 2025, Saba Capital Management sold 45,347 shares of BCAT at a price of $15.44 per share.
• Following this transaction, Saba Capital Management indirectly owns 12,663,820 shares.
• On February 21, 2025, Saba Capital Management sold an additional 29,278 shares at $15.42 per share, resulting in indirect ownership of 12,634,542 shares.
• These transactions were reported on Form 4 filings with the Securities and Exchange Commission (SEC).

Sentiment

Score: 5

Explanation: The document is a routine disclosure of stock sales, indicating a neutral sentiment. It doesn't inherently suggest positive or negative implications for the company's performance.

Negatives

• Saba Capital Management reduced its stake in BlackRock Capital Allocation Term Trust (BCAT).

Industry Context

Form 4 filings are standard practice for reporting changes in beneficial ownership by company insiders, providing transparency to the market.

Stakeholder Impact

• The reduction in Saba Capital Management's stake could potentially influence investor sentiment regarding BlackRock Capital Allocation Term Trust.

Key Dates

Keywords

BlackRock Capital Allocation Term Trust, BCAT, Saba Capital Management, Boaz Weinstein, Form 4, SEC, Beneficial Ownership, Stock Sale